David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 4,517 shares at $10.48 ($49K) on 2019-12-27, disclosed to the SEC on 2020-01-03.
Seasonal sale ($49k) by Chief Accounting Officer — this insider has traded STML in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.58 | 421 | $4K | 9.1% |
| 2 | $10.97 | 2,388 | $26K | 53.5% |
| 3 | $10.75 | 1,511 | $16K | 33.2% |
| 4 | $10.48 | 197 | $2K | 4.2% |
| Total | $10.84 avg | 4,517 | $49K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2019-03-15 | $306K | — | Filing → |